TMC435 (telaprevir)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TMC435 (telaprevir), covering 2014-06-16 to 2014-06-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment [Phase 2]